Clinical Trial

Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

Study acronym: VICTORY
Completed
View on ClinicalTrials.gov →
Summary
A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients
Trial Details
NCT Number NCT07382778
Lead Sponsor JW Pharmaceutical
Conditions Hypercholesterolemia
Enrollment 1,538 participants
Start Date 2022-10-19
Primary Completion 2025-06-13 (estimated)
Study Completion 2025-06-13 (estimated)
Updated on ClinicalTrials.gov 2026-02-03